Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III-Reference-Cited by-同舟云学术

Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III

Published:2010-09 Issue:3 Volume:87 Page:392-399
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Belostotsky Ruth,Seboun Eric,Idelson Gregory H.,Milliner Dawn S.,Becker-Cohen Rachel,Rinat Choni,Monico Carla G.,Feinstein Sofia,Ben-Shalom Efrat,Magen Daniella,Weissman Irith,Charon Celine,Frishberg Yaacov

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference15 articles.

1. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I;Danpure;FEBS Lett.,1986

2. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2;Cregeen;Hum. Mutat.,2003

3. The primary hyperoxalurias;Hoppe;Kidney Int.,2009

4. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II;Monico;Kidney Int.,2002

5. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis;Monico;Am. J. Kidney Dis.,2008

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaluria in inflammatory bowel diseases (review);Koloproktologia;2024-09-21

2. 4-hydroxy-2-oxoglutarate metabolism in a mouse model of Primary Hyperoxaluria Type 3;Biochemistry and Biophysics Reports;2024-09

3. Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory;Kidney International Reports;2024-09

4. Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease;Mayo Clinic Proceedings;2024-07

5. Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3;Kidney International Reports;2024-05